BCM
PRLB icon

Bayesian Capital Management’s Protolabs PRLB Stock Holding History

Bayesian Capital Management’s Portfolio PRLB Stock Details PRLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,031
Closed -$314K – 895
2024
Q4 		$314K Buy
+8,031
New +$289K 0.04% 477
2024
Q1 		– Sell
-5,695
Closed -$222K – 1047
2023
Q4 		$222K Buy
+5,695
New +$184K 0.02% 576
2022
Q2 		– Sell
-4,200
Closed -$222K – 1021
2022
Q1 		$222K Buy
+4,200
New +$221K 0.03% 624
2017
Q2 		– Sell
-9,734
Closed -$497K – 562
2017
Q1 		$497K Buy
+9,734
New +$515K 0.24% 162

Other funds holding PRLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bayesian Capital Management's PRLB Position: Q1 2025 in Review

Bayesian Capital Management sold out of Protolabs (PRLB) in Q1 2025, closing a stake of 8,031 shares — an estimated $314K sold.

Bayesian Capital Management first reported a position in PRLB in Q1 2017 and held it in 4 quarters. The position peaked at $497K in Q1 2017. 188 funds tracked by Wall St. Rank hold PRLB as of Q1 2025.

  • Bayesian Capital Management reported no remaining Protolabs position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 8,031 Protolabs shares in Q1 2025, an estimated $314K.
  • Bayesian Capital Management first reported a position in Protolabs in Q1 2017 and held it in 4 quarters.
  • Bayesian Capital Management's Protolabs position peaked at $497K in Q1 2017.
  • 188 funds tracked by Wall St. Rank held Protolabs as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.